"骨髓状"突变在ALL中并不罕见:对病因学和治疗的含义
1Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee.
Blood cancer discovery
|May 1, 2024
概括
骨髓癌中常见的体质变体出现在16%的成人急性淋巴细胞白血病 (ALL) 中,表明了癌前状态. 这些突变可能先于ALL诊断并影响治疗结果.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 癌症遗传学 癌症遗传学
背景情况:
- 骨髓质恶性瘤的特征是特定的复发性体质变异.
- 这些变体在其他血液癌症,如急性淋巴细胞白血病 (ALL) 中的存在和意义尚未完全理解.
- 克隆性血液形成被认为是髓状癌的前恶性状态.
研究的目的:
- 调查成年急性淋巴细胞白血病 (ALL) 中神经质恶性瘤中复发的体变异的频率和临床影响.
- 在ALL的背景下,探索克隆性血液形成作为癌前状态的潜在作用.
- 评估这些变异对患者年龄,先前治疗史和化疗结果的影响.
主要方法:
- 在成年急性淋巴细胞白血病 (ALL) 患者队列中对体变异的分析.
- 变种存在与临床因素的相关性,包括年龄,先前的基因毒性疗法和治疗结果.
- 研究突变的造血干细胞或原始细胞的细胞起源和分化潜力.
主要成果:
- 在16%的成年ALL病例中发现了骨髓性恶性瘤中复发的体质变异.
- 这些变异的存在与年龄较大,有遗传毒性疗法史和化学疗法结果较差相关.
- 有证据表明,这些突变可以在 ALL 诊断之前的造血干细胞中出现.
结论:
- 在成年ALL中发现的反复发生的骨髓状基因突变的频率很高,这表明共享的前恶性克隆性血液形成.
- 这些发现对理解ALL病因学和开发新型治疗策略具有重要意义.
- 向克隆性血液形成可能为治疗ALL提供新的途径,特别是在老年患者或有先前恶性瘤治疗史的患者中.
相关概念视频
01:15Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
01:22Bone Marrow Sampling and Transplants
326
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
326
01:27Disorders of Leukocytes
941
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
941
01:21Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K